News Update

Revenue-based financing platform N+1 Capital to close its maiden fund of $100 million by the end of September 2022


N+1 Capital, a business that invests in revenue-based growth, has said that it would close its first fund for HNIs and family offices by September 2022. The fund’s ultimate institutional closure for N+1 Capital, which has a target corpus of $100 Mn ($75 Mn + $25 Mn in a greenshoe option), will occur in December 2022.

N+1 Financing, which was established in 2021 by Ashish Singla and Rahul Chowdhury, provides a different way for business owners to raise capital. Companies can still take out small-dollar loans through N+1 Capital without having to dilute their ownership through conventional venture fundraising techniques.

The investment company has already raised 60% of its capital in the last 12 months. The company has already invested Rs 265 Cr from the first fund during the previous four quarters into 30+ startups. It has invested in startups such as Mivi, MoEVing, StanPlus, Provet Pharma, Clensta Tech, and Teamonk Global Foods on a revenue-based, non-dilutive basis.

Revenue-based financing platform N+1 Capital to close its maiden fund of $100 million by the end of September 2022

N+1 intends to distribute Rs 100 Cr across 8–12 enterprises per quarter as it obtains further cash. It will sign checks between Rs 8 Cr and Rs 15 Cr for investee businesses with consistent cash flows and at least Rs 15 Cr in sales. The portfolio of startups owned by N+1 Capital with the greatest revenue now has a turnaround of Rs 240 Cr.

The new investment asset class is intended to replace equity and debt capital, which are used for CAPEX, by giving businesses access to OPEX (operational expenditure or working capital). In the AIF sector, N+1 Capital, an alternative to debt financing, contends with companies like Kred, Get Vantage, and BHive, among others. By 2025, the market for investing in technology is expected to reach $14.3 billion.

Follow Startup Story

Related Posts

© Startup Story Private Limited. All Rights Reserved.